Search filters

Filters
Clear All

Phase

  • 1
  • 11
  • 15
  • 13
  • 13

Found 15 Acute Lymphocytic Leukemia trials

A listing of Acute Lymphocytic Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

2 years - 21 years
All genders
This study investigates treatments for Philadelphia chromosome positive acute lymphoblastic leukemia (ALL), a type of cancer affecting the blood and bone marrow. The purpose of this study is to examine the effectiveness of combining an investigational medication with different chemotherapy approaches to improve disease-free survival in children with standard risk …
18 years - 65 years
All genders
This study investigates a new type of radiation therapy called total marrow irradiation (TMI) for patients undergoing allogeneic hematopoietic stem cell transplantation (Allo-HSCT). It aims to find the most effective dose of TMI when used with a chemotherapy drug called fludarabine. This combination is used to prepare patients for the …
1 years - 30 years
All genders
This study investigates the effectiveness of an investigational medication for treating children and young adults with acute lymphoblastic leukemia or lymphoblastic lymphoma. Acute lymphoblastic leukemia is a type of cancer that affects the blood and bone marrow, while lymphoblastic lymphoma is a similar cancer affecting lymph nodes. The study aims …
100 years or below
All genders
This study investigates the use of an investigational treatment for patients with certain types of blood cancer, specifically acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL). These patients have a special need due to their leukapheresis product not meeting standard specifications. Leukapheresis is a procedure to collect blood …
50 years - 90 years
All genders
Phase 3
This study investigates an investigational medication for people with early Alzheimer's Disease (AD), which includes mild cognitive impairment or mild dementia. AD is marked by a build-up of an abnormal protein called amyloid in the brain, which can affect memory and thinking. The investigational medication is a monoclonal antibody, meaning …
11 - 15 of 15